![EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of torrile, advertising: 128728021 EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of torrile, advertising: 128728021](https://thumbs.dreamstime.com/z/san-polo-di-torrile-italy-october-sunight-enlightening-gsk-logo-plant-fostemsavir-innovative-anti-hiv-drug-day-128728021.jpg)
EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of torrile, advertising: 128728021
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW64TM/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64TM.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000490/110218250-san-polo-di-torrile-italy-october-12-2018-gsk-italian-and-viiv-flags-waving-together-on-plant.jpg)
San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture
![EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898 EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898](https://thumbs.dreamstime.com/z/san-polo-di-torrile-italy-october-sunight-enlightening-gsk-logo-plant-fostemsavir-innovative-anti-hiv-drug-day-128728898.jpg)
EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WDW/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WDW.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64GP/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64GP.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64E2/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64E2.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64H0/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64H0.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW64TY/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64TY.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Welcomes Visitors At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Welcomes Visitors At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000587/110051949-san-polo-di-torrile-italy-october-12-2018-luis-arosemena-president-and-ceo-at-gsk-italy-welcomes.jpg)
San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Welcomes Visitors At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WE0/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WE0.jpg)